David Ebrahimzadeh, Corniche Capital CEO & NAIA member, to attend Reindustrialize 2026 Detroit — seeking manufacturers, defense startups & powered land.
Proprietary AI-powered market intelligence and specialized advisory services mark a structural shift in how laundromat operators and institutional investors find and launch new laundromats.NEW...
NOVI, Mich., June 3, 2026 /PRNewswire/ -- Stoneridge, Inc. today announced the appointment of Scott Humphrey to the position of chief financial officer and...
NEW YORK, June 3, 2026 /PRNewswire/ -- Backcast Partners ("Backcast"), a provider of debt and equity capital to both middle-market private equity backed and...
Seasoned finance executive brings deep experience scaling growth-stage companies and advancing strategic commercializationWOODBRIDGE, Conn., June 3, 2026 /PRNewswire/ -- P2 Science, Inc., a leading green...
TOKYO and NEW YORK, June 03, 2026 (GLOBE NEWSWIRE) -- Apollo (NYSE: APO) announced that Apollo-managed funds (the “Apollo Funds”) completed the sale of their interest in ALTEMIRA Holdings Co., Ltd. (“ALTEMIRA” or the “Company”), a leading pan-Asian aluminum packaging company, to funds managed by MBK Partners.
MIAMI, June 02, 2026 (GLOBE NEWSWIRE) -- PennantPark Floating Rate Capital Ltd. (the "Company") (NYSE: PFLT) declares its monthly distribution for June 2026 of $0.0833 per share, comprised of an $0.08 per share base dividend and $0.0033 per share supplemental dividend, payable on July 1, 2026 to stockholders of record as of June 15, 2026. The distribution is expected to be paid from taxable net investment income. The final specific tax characteristics of the distribution will be reported to stockholders on Form 1099 after the end of the calendar year and in the Company's periodic report filed with the Securities and Exchange Commission.
STAMFORD, Conn. and HOUSTON, June 2, 2026 /PRNewswire/ -- Trillium Flow Technologies ("Trillium"), a portfolio company of First Reserve and a leading provider of...
Experienced healthcare and life sciences executive to lead the Company's next phase of growth and innovationEXTON, Pa., June 1, 2026 /PRNewswire/ -- West Pharmaceutical...